ONETOUCH REVEAL® PLUS

A Digital Coach For 24/7 Support

OneTouch Reveal® Plus, powered by award-winning BlueStar® technology, is a digital diabetes coaching solution designed to help improve self-care. Now available on the Express Scripts Digital Health Formulary.

Now with expanded FDA clearance for people with Type 1 diabetes

OneTouch Reveal® Plus Mobile App Features Digital Health Formulary
Digital Coaching Fulfills a Real Need

Digital Coaching Fulfills a Real Need

As people strive to live well with diabetes, many need real-time support to help improve their daily self-care.

Did you know?

 

 

50% of people with diabetes are not achieving glycemic targets.1

70% of people with diabetes fail to recognize a high blood glucose level.2

54% on Insulin say they do not respond regularly to high or low blood glucose readings.3

The OneTouch Reveal® Plus app has been designed to support the key self-care skills identified by the ADA and the AADE as essential for living well with diabetes. The digital diabetes coach puts data-driven technology to work for patients, care teams and health plans.

    Personalized Coaching Anytime, Anywhere

    AI technology provides thousands of customized messages to help guide people with diabetes through high or low episodes.

    OTRPlus app

    Find Food Within Carb Range

    Snap a picture, scan barcodes, or use the restaurant helper to help make smarter dietary choices.

    OTRPlus app

    Care Team Integration

    SMART Visit Reports and data sharing tools help to improve engagement and communication with care teams.

    OTRPlus app

    Certified Diabetes Educators

    Empower self-care and get extra support with access to a team of educators and OneTouch U.

    OTRPlus app

    Syncs to Health Devices

    Seamlessly integrates with select activity trackers, weight and blood pressure devices, and glucose meters.

    OTRPlus app
    Personalized Coaching Anytime, Anywhere

    AI technology provides thousands of customized messages to help guide people with diabetes through high or low episodes.

    Find Food Within Carb Range

    Snap a picture, scan barcodes, or use the restaurant helper to help make smarter dietary choices.

    Care Team Integration

    SMART Visit Reports and data sharing tools help to improve engagement and communication with care teams.

    Certified Diabetes Educators

    Empower self-care and get extra support with access to a team of educators and OneTouch U.

    Syncs to Health Devices

    Seamlessly integrates with select activity trackers, weight and blood pressure devices, and glucose meters.

    For Employers

    For Health Plans and Systems

    For Individuals

    For Employers

    For Health Plans and Systems

    For Individuals

    The OneTouch Reveal® Plus app, powered by BlueStar®, is indicated for use by patients aged 18 and older who have Type 1 or Type 2 diabetes and their healthcare providers. The app is not intended to replace the care provided by a licensed healthcare professional. The app should not be used by patients with gestational diabetes or patients using an insulin pump. BlueStar® is a Welldoc, Inc. patented system. The OneTouch Reveal® Plus app is manufactured by Welldoc, Inc.

    1Carls G, et al. Achievement of Glycated Hemoglobin Goals in the US Remains Unchanged Through 2014. Diabetes Ther. 2017 Aug;8(4):863-873. (doi: 10.1007/s13300-017-0280-5) Epub 2017 June 23. Based on recent National Health and Nutrition Examination Survey (NHANES) from 2007-2014 with data from 2677 adults.

    2Evans JMM, et al. Self-monitoring of blood glucose in type 2 diabetes: patients’ perceptions of ‘high’readings. Diabetes Res Clin Pract 2013; 102 (1):e5-e7. doi: http://dx.doi.org/10.1016/j.diabres.2013.07.011. Based on results of 207 non-insulin using patients, 28% correctly identified a blood glucose reading of 393>235 mg/dL as a high result.

    3Polonsky Wh, et al. A survey of blood glucose monitoring in patients with type 2 diabetes: are recommendations from health care professionals being followed? Curr Med Res Opin 2011;27 (suppl 3):31-37. Based on patient-reported use of SMBG data, 54% of 320 patients said they take no action in response to highs and lows.

    *https://www.diabetes.org/resources/statistics/cost-diabetes

    US-OTRP-2000002